eosinophil differentiation factor - Books

Result Filters

Results: 1 to 20 of 87 books (256 items)

<< First< Prev

Page of 5

Next >Last >>

Select item 44036681.

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2024 Jan-.

Top results in this book Table of Contents

Select item 16541062.

Immunobiology: The Immune System in Health and Disease. 5th edition.

Janeway CA Jr, Travers P, Walport M, et al.

New York: Garland Science; 2001.

Top results in this book Table of Contents

Select item 16686903.

Holland-Frei Cancer Medicine. 6th edition.

Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.

Hamilton (ON): BC Decker; 2003.

Top results in this book Table of Contents

Select item 44914404.

Reslizumab (Cinqair) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.

Top results in this book Table of Contents

Select item 14152805.

Madame Curie Bioscience Database [Internet].

Austin (TX): Landes Bioscience; 2000-2013.

Top results in this book Table of Contents

Select item 55261046.

Green–blue space exposure changes and impact on individual-level well-being and mental health: a population-wide dynamic longitudinal panel study with linked survey data.

Geary RS, Thompson DA, Garrett JK, et al.

Southampton (UK): National Institute for Health and Care Research; 2023 Oct. (Public Health Research, No. 11.10.)

Top results in this book Table of Contents

Select item 47763267.

Clinical Review Report: Benralizumab (Fasenra): (AstraZeneca Canada Inc.): Indication: An add-on maintenance treatment of adult patients with severe eosinophilic asthma [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.

Top results in this book Table of Contents

Select item 43690808.

Mepolizumab (Nucala) [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Nov.

Top results in this book Table of Contents

Select item 34012949.

Endotext [Internet].

Feingold KR, Anawalt B, Blackman MR, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

Top results in this book Table of Contents

Select item 446506410.

Autoimmunity: From Bench to Bedside [Internet].

Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors.

Bogota (Colombia): El Rosario University Press; 2013 Jul 18.

Top results in this book Table of Contents

Select item 426894811.

Scoping systematic review of treatments for eczema.

Nankervis H, Thomas KS, Delamere FM, et al.

Southampton (UK): NIHR Journals Library; 2016 May. (Programme Grants for Applied Research, No. 4.7.)

Top results in this book Table of Contents

Select item 558895212.

Tezepelumab (Tezspire): CADTH Reimbursement Review: Therapeutic area: Asthma [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.

Top results in this book Table of Contents

Select item 485381613.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

Top results in this book Table of Contents

Select item 551867614.

Dupilumab (Dupixent): CADTH Reimbursement Review: Therapeutic area: Asthma [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Apr.

Top results in this book Table of Contents

Select item 558852615.

Mepolizumab (Nucala): CADTH Reimbursement Review: Therapeutic area: Severe chronic rhinosinusitis with nasal polyps [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Feb.

Top results in this book Table of Contents

Select item 435088816.

A randomised placebo-controlled trial investigating efficacy and mechanisms of low-dose intradermal allergen immunotherapy in treatment of seasonal allergic rhinitis.

Slovick A, Douiri A, Muir R, et al.

Southampton (UK): NIHR Journals Library; 2016 Dec. (Efficacy and Mechanism Evaluation, No. 3.10.)

Top results in this book Table of Contents

Select item 329411217.

Indoor Allergens: Assessing and Controlling Adverse Health Effects.

Institute of Medicine (US) Committee on the Health Effects of Indoor Allergens; Pope AM, Patterson R, Burge H, editors.

Washington (DC): National Academies Press (US); 1993.

Top results in this book Table of Contents

Select item 157491618.

Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma.

National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma.

Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug.

Top results in this book Table of Contents

Select item 539355619.

Leukemia [Internet].

Li W, editor.

Brisbane (AU): Exon Publications; 2022 Oct 16.

Top results in this book Table of Contents

Select item 456572820.

Drugs and Lactation Database (LactMed®) [Internet].

Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Top results in this book Table of Contents

<< First< Prev

Page of 5

Next >Last >>

Supplemental Content

Images search in Bookshelf

Figure 2-3

AIRWAY INFLAMMATION
Inhaled antigen activates mast cells and Th2 cells in the airway. They in turn induce the production of mediators of inflammation (such as histamine and leukotrienes) and cytokines including interleukin-4 and interleukin-5. Interleukin-5 travels to the bone marrow and causes terminal differentiation of eosinophils. Circulating eosinophils enter the area of allergic inflammation and begin migrating to the lung by rolling, through interactions with selectins, and eventually adhering to endothelium through the binding of integrins to members of the immunoglobulin superfamily of adhesion proteins: vascular-cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). As the eosinophils enter the matrix of the airway through the influence of various chemokines and cytokines, their survival is prolonged by interleukin-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF). On activation, the eosinophil releases inflammatory mediators, such as leukotrienes and granule proteins, to injure airway tissues. In addition, eosinophils can generate GM-CSF to prolong and potentiate their survival and contribution to persistent airway inflammation. MCP-1, monocyte chemotactic protein; and MIP-1α, macrophage inflammatory protein.
Reprinted by permission from Busse WW, Lemanske RF. Advances in Immunology N Engl J Med 2001; 344: 350-62. Copyright © 2001 Massachusetts Medical Society. All rights reserved.

Section 2, Definition, Pathophysiology and Pathogenesis of Asthma, and Natural History of Asthma.

National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug.